BIO NATURE BIOTECH CO., LTD.
Update:2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Stem Cell-based Therapeutic Drugs:
Bronchopulmonary dysplasia
Cerebral palsy
Ischemia Stroke
Chronic Obstructive Pulmonary Disease
Acute Respiratory Distress Syndrome
Bronchopulmonary dysplasia
Cerebral palsy
Ischemia Stroke
Chronic Obstructive Pulmonary Disease
Acute Respiratory Distress Syndrome
The content above was translated by Ai
Founded Year
2011
Unified Business No.
53562161
Status
Active
Number of Employees
0
Total Paid-in
Capital
13,000,080 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Meridigen Biotech is a technology development firm that specializes in the advancement of technologies related to mesenchymal stem cells.
The content above was translated by Ai